1. Long noncoding RNAs as biotargets in cisplatin-based drug resistance
   Nadiah Abu et al, 2018, Future Oncology CrossRef
2. LncRNA AWPPH as a prognostic predictor in human cancers in Chinese population: evidence from meta-analysis
   Yongfeng Li et al, 2021, Bioscience Reports CrossRef
3. LncRNA MIR4435-2HG suppression regulates macrophage M1/M2 polarization and reduces intestinal inflammation in mice with ulcerative colitis
   Li Cao et al, 2023, Cytokine CrossRef
4. Long noncoding RNA LINC00461 mediates cisplatin resistance of rectal cancer via miR-593-5p/CCND1 axis
   Wei Qu et al, 2020, Biomedicine & Pharmacotherapy CrossRef
5. Long non-coding RNAs and cancer metastasis: Molecular basis and therapeutic implications
   Hui Ming et al, 2021, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
6. Long non‐coding RNA FTH1P3 activates paclitaxel resistance in breast cancer through miR‐206/ABCB1
   Ruoming Wang et al, 2018, Journal of Cellular and Molecular Medicine CrossRef
7. Silencing of Long Non-coding RNA MIAT Sensitizes Lung Cancer Cells to Gefitinib by Epigenetically Regulating miR-34a
   Yunfeng Fu et al, 2018, Frontiers in Pharmacology CrossRef
8. LncRNAs and miRNAs participate in determination of sensitivity of cancer cells to cisplatin
   Mohammad Taheri et al, 2021, Experimental and Molecular Pathology CrossRef
9. GTSE1 is possibly involved in the DNA damage repair and cisplatin resistance in osteosarcoma
   Chaofan Xie et al, 2021, Journal of Orthopaedic Surgery and Research CrossRef
10. Long non-coding RNAs as a determinant of cancer drug resistance: Towards the overcoming of chemoresistance via modulation of lncRNAs
    Wenxiao Jiang et al, 2020, Drug Resistance Updates CrossRef
11. Long noncoding RNA LINC00978 acts as a potential diagnostic biomarker in patients with colorectal cancer
    Majid Ghasemian et al, 2021, Experimental and Molecular Pathology CrossRef
12. New insights into long non-coding RNAs in non-small cell lung cancer
    Ruifang Ye et al, 2020, Biomedicine & Pharmacotherapy CrossRef
13. Identification of NLE1/CDK1 axis as key regulator in the development and progression of non-small cell lung cancer
    Pei Xu et al, 2023, Frontiers in Oncology CrossRef
14. MIR4435-2HG Is a Potential Pan-Cancer Biomarker for Diagnosis and Prognosis
    Chenming Zhong et al, 2022, Frontiers in Immunology CrossRef
15. Long non‑coding RNA ENST00000500843 is downregulated and promotes chemoresistance to paclitaxel in lung adenocarcinoma
    Xin Tian et al, 2019, Oncology Letters CrossRef
16. LncRNA AK001796 promotes cell proliferation via acting as a ceRNA of miR-150 in hepatocellular carcinoma
    Rui Xu et al, 2023, Genetics and Molecular Biology CrossRef
17. Long non‐coding RNAs as potential biomarkers in the prognosis and diagnosis of lung cancer: A review and target analysis
    Younes Aftabi et al, 2021, IUBMB Life CrossRef
18. LINC00511 Knockdown Suppresses Resistance to Cisplatin in Lung Adenocarcinoma by Interacting with miR-182-3p and BIRC5
    Zhongcheng Zhu et al, 2022, Molecular Biotechnology CrossRef
19. LncRNA MIR4435-2HG targets desmoplakin and promotes growth and metastasis of gastric cancer by activating Wnt/β-catenin signaling
    Haiyong Wang et al, 2019, Aging CrossRef
20. Emerging role of non-coding RNAs in resistance to platinum-based anti-cancer agents in lung cancer
    Priya Mondal et al, 2023, Frontiers in Pharmacology CrossRef
21. LINC00978 promotes hepatocellular carcinoma carcinogenesis partly via activating the MAPK/ERK pathway
    Quan Zhang et al, 2020, Bioscience Reports CrossRef